Testing a new COPD support system in pharmacies
Part of Lungs & breathing clinical trials.
This study tests a new system called EAPOC-COPD that helps pharmacists support people with COPD. It aims to see if the system is useful and easy to use during regular pharmacy visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have COPD and receive care at one of the participating pharmacies.
- You are willing to fill out a questionnaire about the system during your pharmacy visit.
- You are okay with being contacted about the research.
- You can give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a structured review process to help people with COPD who have needed multiple steroid pills in the past year. It aims to improve care and prevent future harm from the condition.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study tests a home-based program that provides education and activity guidance for people with COPD who have been hospitalized in the past year. It aims to help you understand your condition better and stay active safely.
This study tests a smartphone app designed to help you track and manage your COPD symptoms day-to-day. It includes a small device you use at home to measure your lung function, aiming to help you catch problems early and stay healthier.
This trial looks at whether using one or more inhalers, together with a smartphone app, can help people manage chronic obstructive pulmonary disease (COPD) better. You may be eligible if you have COPD, need “triple therapy” (three medicine types), and can use the app and surveys.
This study tracks the health of people with COPD who are receiving their usual treatments. It helps doctors learn more about how the disease affects people over time and aims to improve care.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.